Elbasvir/Grazoprevir Experience - A New Glance at HCV Treatment: Case Report
Journal Title: Viral Hepatitis Journal - Year 2017, Vol 23, Issue 1
Abstract
Hepatitis C is a viral disease having a worldwide importance and posing a risk for liver complications. With the new treatment options, it is easy to manage with higher rates of success. Among them, one of the most recent one is elbasvir/grazoprevir option. This study presents the results of two treatment-naive patients treated with elbasvir/grazoprevir. The first case was a male non-cirrhotic patient and the second one was a female who suffered from compensated hepatic cirrhosis. Both patients received elbasvir/grazoprevir 50/100 mg in a single tablet for 12 weeks. Persistent viral response was achieved in both patients and no side effect was observed during the treatment. Elbasvir/grazoprevir combination, one of the recent treatments, was considered effective and tolerable.
Authors and Affiliations
Mustafa Kemal ÇELEN, İrem AKDEMİR, Recep TEKİN, Kadim BAYAN, Celal AYAZ
Keywords
Related Articles
- EP ID EP228501
- DOI 10.4274/vhd.10337
- Views 57
- Downloads 0
Immunosuppressive Therapy and Hepatitis B Virus Reactivation
Reactivation of hepatitis B virus (HBV) refers to reappearance of active necroinflammatory disease of the liver in an individual at an inactive hepatitis B surface antigen carrier state or who is known to have resolved H...
Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals
Objective: Chronic hepatitis C (CHC) virus infection is one of the leading causes of chronic liver disease in all over the world. The prevalence of CHC is almost 0.5-1% in Turkey. Until recently, pegylated-interferon (PE...
Elbasvir/Grazoprevir Experience - A New Glance at HCV Treatment: Case Report
Hepatitis C is a viral disease having a worldwide importance and posing a risk for liver complications. With the new treatment options, it is easy to manage with higher rates of success. Among them, one of the most recen...
Impact of Direct Acting Antiviral Agents on Psychiatric and Sexual Health of Patients with Hepatitis C Virus
Objectives: Data about the psychosocial side effects of directacting antiviral agents (DAA) used for the treatment of hepatitis C virus (HCV) infection is scarce. In this study, it is aimed to assess the psychiatric and...
Seroepidemiology of Hepatitis B Virus Infection in İstanbul: A 20-year Survey
Objective: Turkey is an intermediate endemic country for hepatitis B virus (HBV) infection, with the prevalence rates showing regional differences. The aim of this study was to determine the recent prevalence of HBV infe...